Shares of Cochlear Limited (OTCMKTS:CHEOF – Get Free Report) were up 7.2% on Tuesday . The company traded as high as $78.14 and last traded at $78.14. Approximately 20 shares traded hands during trading, a decline of 99% from the average session volume of 1,490 shares. The stock had previously closed at $72.9110.
Cochlear Price Performance
The business’s 50 day moving average price is $77.82 and its 200-day moving average price is $131.65.
Cochlear Company Profile
Cochlear (OTCMKTS:CHEOF) is a global medical device company specializing in implantable hearing solutions. The company researches, develops, manufactures and markets cochlear implants, bone conduction hearing devices and acoustic implants designed to improve hearing outcomes for individuals with varying degrees of hearing loss. Cochlear’s product portfolio includes implant processors, electrode arrays and sound processor accessories, supported by proprietary digital signal processing technologies.
Founded in 1981 and headquartered in Sydney, Australia, Cochlear has grown into a multi-national organization with operations in North America, Europe, Asia Pacific and Latin America.
See Also
- Five stocks we like better than Cochlear
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
